View Older Stories View More Recent Stories

Dec 20, 2021 08:00AM UNITY Biotechnology Announces Exclusive License Agreement with Jocasta Neuroscience to Continue Development of α-Klotho Program
Nov 10, 2021 08:00AM UNITY Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates
Nov 9, 2021 07:00AM UNITY Biotechnology Announces Improvement in Visual Acuity Sustained Through 24 Weeks Following Single Dose of UBX1325 in Phase 1 Study of Patients with Advanced Vascular Eye Disease
Nov 3, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Oct 6, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Oct 5, 2021 07:02AM UNITY Biotechnology (UBX) Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Advanced Vascular Eye Disease
Oct 5, 2021 07:00AM UNITY Biotechnology Announces Positive 12-Week Data from Phase 1 Clinical Trial of UBX1325 in Advanced Vascular Eye Disease
Sep 7, 2021 04:00PM UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
Aug 18, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Aug 16, 2021 04:03PM UNITY Biotechnology, Inc. to Participate in the H.C. Wainwright Ophthalmology Virtual Conference
Aug 10, 2021 04:01PM UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business Updates
Jul 28, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Jul 23, 2021 08:00AM UNITY Biotechnology to Host Investor Call with Retinal Expert Robert Bhisitkul, M.D., Ph.D., to Discuss Recent Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular E
Jul 6, 2021 07:00AM UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease
Jun 2, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
May 11, 2021 08:00AM UNITY Biotechnology, Inc. Reports First Quarter 2021 Financial Results and Business Updates
May 1, 2021 07:00AM UNITY Biotechnology Presents UBX1325 Data Demonstrating Improvement in Retinal Vasculature and Function in Preclinical Models of Diabetic Retinopathy Eye Diseases
Apr 28, 2021 08:00AM UNITY Biotechnology to Present Preclinical Data on Clinical Candidate Molecule UBX1325 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
Apr 21, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Mar 23, 2021 04:01PM UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates
Mar 11, 2021 04:05PM UNITY Biotechnology Reports Granting of New Employment Inducement Award
Mar 8, 2021 08:00AM UNITY Biotechnology Announces Appointment of Alexander Nguyen as General Counsel
Feb 26, 2021 04:05PM UNITY Biotechnology to Participate in Upcoming March Investor Conferences
Feb 24, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Feb 8, 2021 08:00AM Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease
Feb 3, 2021 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Feb 1, 2021 08:00AM UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor
Dec 16, 2020 08:00AM UNITY Biotechnology Reports Granting of New Employment Inducement Awards
Dec 14, 2020 07:00AM UNITY Biotechnology Announces Appointment of Clinical Development and Industry Veteran Gilmore O’Neill, M.B., to the Board of Directors
Nov 4, 2020 04:01PM UNITY Biotechnology, Inc. Reports Third Quarter 2020 Financial Results and Clinical Program Updates
Oct 12, 2020 08:09AM UNITY Biotechnology (UBX) Reports First Patient Dosed in Phase 1 Study of UBX1325 in Diabetic Macular Edema
Oct 12, 2020 08:00AM UNITY Biotechnology Announces First Patient Dosed in Phase 1 Study of UBX1325 in Diabetic Macular Edema
Sep 15, 2020 08:13AM UNITY Biotechnology (UBX) Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
Sep 15, 2020 08:00AM UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
Sep 4, 2020 08:00AM UNITY Biotechnology to Participate in Upcoming September Investor Conferences
Aug 31, 2020 04:15PM UNITY Biotechnology (UBX) Announces Appointment of Lynne Sullivan as CFO
Aug 31, 2020 04:05PM UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
Aug 17, 2020 07:05AM UNITY Biotechnology (UBX) Reports 12-Wk Data from UBX101 Phase 2 Clinical Study in Patients w/ Osteoarthritis of the Knee Painful
Aug 17, 2020 07:00AM UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee
Aug 4, 2020 04:05PM UNITY Biotechnology Announces $80M Debt Financing From Hercules Capital
Jul 31, 2020 07:57AM UNITY Biotechnology, Inc. Reports Second Quarter 2020 Financial Results and Clinical Program Updates
Jul 29, 2020 04:05PM UPDATE – UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
Jul 24, 2020 08:00AM UNITY Biotechnology, Inc. to Announce Second Quarter 2020 Financial Results
Jul 6, 2020 05:03PM UNITY Biotechnology (UBX) Announces CFO Transition
Jul 6, 2020 05:00PM UNITY Biotechnology Announces CFO Transition
Jul 1, 2020 04:05PM UNITY Biotechnology, Inc. Provides Updates on Lead Development Programs
Jun 11, 2020 02:31PM UNITY Biotechnology to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare Conference
May 28, 2020 04:05PM UNITY Biotechnology to Participate in the Goldman Sachs 41st Annual Global Healthcare Conference
May 7, 2020 04:05PM UNITY Biotechnology, Inc. Reports First Quarter 2020 Financial Results and Business Updates
May 4, 2020 04:30PM UNITY Biotechnology, Inc. to Announce First Quarter 2020 Financial Results
View More Recent Stories View Older Stories